Pain: Basics and relevance in dermatology: Academy CME

JDDG - Journal of the German Society of Dermatology

Volumn 7, Issue 8, 2009, Pages 704-716

  Nashan, Dorothée ^a,c   Meiss, Frank ^a   Gralow, Ingrid ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Clinic and Polyclinic For Anesthesiology and Operative Intensive Medicine   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Analgesic therapy; Cancer pain; Neuropathic; Nociceptive; Pain; Postherpetic

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIPYRETIC ANALGESIC AGENT; ARSENIC; BENZYDAMINE; BUPRENORPHINE; CAPSAICIN; CARBAMAZEPINE; CISPLATIN; CORTICOSTEROID; DIPYRONE; FENTANYL; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEXILETINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXCARBAZEPINE; PARACETAMOL; PAROXETINE; PREGABALIN; REBOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCRISTINE;

AGRANULOCYTOSIS; ALLODYNIA; ANALGESIA; ANALGESIC ACTIVITY; ANTIPYRETIC ACTIVITY; ARTHRALGIA; BREAKTHROUGH PAIN; CANCER PAIN; CHRONIC PAIN; CLINICAL FEATURE; COMPLEX REGIONAL PAIN SYNDROME; DERMATOLOGY; DISEASE CLASSIFICATION; DRUG HALF LIFE; DRUG MECHANISM; DYSESTHESIA; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERALGESIA; HYPERESTHESIA; HYPESTHESIA; HYPOALGESIA; LIVER TOXICITY; MYALGIA; NEPHROTOXICITY; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTIVE PAIN; NOCICEPTIVE STIMULATION; PAIN; PAIN ASSESSMENT; PARESTHESIA; PATHOPHYSIOLOGY; PHYSIOTHERAPY; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PSYCHOTHERAPY; REVIEW; SENSITIZATION; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

EID: 68549094389     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2009.07032.x     Document Type: Review

References (46)

1. Ugurel S, Enk A. Skin cancer: follow-up, rehabilitation, palliative and supportive care. J Dtsch Dermatol Ges 2008 6 : 492 8 quiz 499.
2. Waxman SG, Dib-Hajj S. Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med 2005 11 : 555 62.
3. Coulling S. Fundamentals of pain management in wound care. Br J Nurs 2007 16 : S4 6, S8, S10 passim.
4. Tyring SK. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol 2007 57 : S136 42.
5. Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry 2008 69 Suppl 2 : 6 13.
6. Giamberardino MA. Update on Fibromyalgia Syndrome. Pain: Clinical Updates 2008 XVI : 1 6.
7. Großkopf V, Schanz M. Schmerztherapie - Herausforderung für die Praxis. Rechtsde-pesche für das Gesundheitswesen 2005 : 138 41.
8. Baron R. Diagnostik und Therapie neuropathischer Schmerzen. Deutsches Ärzteblatt 2006 103 : 2720 30.
9. Stengel M, Maag R, Baron R. Krankheitsmechanismen neuropathischer Schmerzen: ein Ausblick. Journal für Neurologie, Neurochirurgie und Psychiatrie 2006 7 : 9 15.
10. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000 288 : 1765 9.
11. Dray A. Neuropathic pain: emerging treatments. Br J Anaesth 2008 101 : 48 58.
12. Janig W, Baron R. Is CRPS I a neuropathic pain syndrome? Pain 2006 120 : 227 9.
13. Baron R. Mechanisms of Disease: neuropathic pain - a clinical perspective. Nature Clinical Practice Neurology 2006 2 : 95 106. (Pubitemid 43210250)
14. Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain 2006 7 : S3 S12.
15. Aurilio C, Pota V, Pace MC, Passavanti MB, Barbarisi M. Ionic channels and neuropathic pain: physiopathology and applications. J Cell Physiol 2008 215 : 8 14.
16. Diener HC, Putzki N, Berlit P. Leitlinien für Diagnostik und Therapie in der Neurologie, Georg Thieme Verlag, Stuttgart, 2005.
17. Baron R. [Neuropathic pain. The long path from mechanisms to mechanism-based treatment]. Anaesthesist 2000 49 : 373 86.
18. Horowitz SH. The diagnostic workup of patients with neuropathic pain. Med Clin North Am 2007 91 : 21 30.
19. Freynhagen R, Junker U. Update: Therapie von Tumorschmerzen. Schmerztherapie 2007 23 : 12 17.
20. Bennett MI, Attal N, Backonja MM, Baron R, Bouhassira D, Freynhagen R, Scholz J, Tolle TR, Wittchen HU, Jensen TS. Using screening tools to identify neuropathic pain. Pain 2007 127 : 199 203.
21. Wassilew SW. Zoster-associated neuralgias. J Dtsch Dermatol Ges 2006 4 : 871 9 quiz 880-1.
22. Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother 2007 7 : 1581 95.
23. Ludwig J, Baron R. [Stepped analgesic approach to herpes zoster pain]. MMW Fortschr Med 2006 148 : 41 3.
24. Gralow I. Nichtopiodanalgetika. In : Gralow I. HIW, Bothe H.-W., Evers S., Hürter A., Schilgen A. : Schmerztherapie interdisziplinär. Stuttgart : Schattauer GmbH, 2002 : 302 7.
25. Zernikow B, Hechler T. Schmerztherapie bei Kindern und Jugendlichen. Deutsches Ärzteblatt 2008 105 : 511 21.
26. Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 2002 58 : 265 74.
27. Arzneimittelkommission. Tumorschmerzen. 2007 Edition: Arzneimittelkommission der deutschen Ärzteschaft, 2007 : 1 36.
28. DeLeo JA. Basic science of pain. J Bone Joint Surg Am 2006 88 Suppl 2 : 58 62.
29. Sorge J, Luders B, Werry C, Pichlmayr I. [Supply of opioid analgesics to outpatients with cancer pain]. Schmerz 1996 10 : 283 91.
30. Nauck F, Eulitz N. Tumorschmerztherapie. Der Onkologe 2007 13 : 865 78.
31. Kreutzberg K. Therapieoptionen bei Durchbruchschmerzen. Onkologie 2007 : 53.
32. Gerbershagen HJ, Dagtekin O, Sabatowski R. Opioide - wann welche Applikations-form? Arzneimitteltherapie 2007 25 : 374 82.
33. Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 2002 100 : 213 7.
34. Angster R. Therapie vonTumorschmerzen. In : Schlimok G : Supportivtherapie in der Hämatologie-Onkologie. Bremen : UNI-MED, 2004.
35. Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev 2007 : CD003868.
36. Ludwig J, Baron R. Greifen Sie ein, bevor der Schmerz chronisch wird. MMW Fortschr Med 2005 147 : 76 8.
37. Gross G, Schofer H, Wassilew S, Friese K, Timm A, Guthoff R, Pau HW, Malin JP, Wutzler P, Doerr HW. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003 26 : 277 89 discussion 291-3.
38. Hempenstall K, Nurmikko TJ, Johnson RW, A'Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005 2 : e164.
39. Wasner G, Naleschinski D, Binder A, Schattschneider J, McLachlan EM, Baron R. The effect of menthol on cold allodynia in patients with neuropathic pain. Pain Med 2008 9 : 354 8.
40. Lander JA, Weltman BJ, So SS. EMLA and amethocaine for reduction of children's pain associated with needle insertion. Cochrane Database Syst Rev 2006 3 : CD004236.
41. Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008 24 : 142 54.
42. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003 361 : 690 4.
43. Ständer S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008 17 : 161 9.
44. Bandolier. Topical Analgesics: A Review of Reviews and a Bit of Perspective. Bandolier 2005 : 1 22.
45. Binder A, Baron R. Sodium channels in neuropathic pain - friend or foe? Nat Clin Pract Neurol 2007 3 : 179.
46. Hosking RD, Zajicek JP. Therapeutic potential of cannabis in pain medicine. Br J Anaesth 2008 101 : 59 68.